TABLE 4.
Univariable and multivariable Cox regression analysis of the signature and survival of NFPA patients in the training, test group and entire group.
| Variables | Univariable analysis | Multivariable analysis | |||||||
|---|---|---|---|---|---|---|---|---|---|
| HR | 95% CI of HR | P | HR | 95% CI of HR | P | ||||
| Lower | Upper | Lower | Upper | ||||||
| Training set (n = 33) | |||||||||
| Age | >52 vs.≤52 | 0.23 | 0.05 | 1.09 | 0.06 | 0.18 | 0.03 | 1.08 | 0.06 |
| Sex | Male vs. Female | 1.05 | 0.29 | 3.74 | 0.94 | 0.73 | 0.17 | 3.11 | 0.68 |
| Tumor size classification | Macro vs. Giant | 1.10 | 0.23 | 5.18 | 0.91 | 1.19 | 0.18 | 7.72 | 0.85 |
| CS invasion | Yes vs. No | 1.40 | 0.36 | 5.40 | 0.63 | 1.37 | 0.28 | 6.59 | 0.70 |
| Signature | High risk vs. low risk | 2.03 | 1.40 | 2.94 | <0.001 | 2.06 | 1.36 | 3.12 | <0.001 |
| Test set (n = 33) | |||||||||
| Age | >52 vs.≤52 | 0.35 | 0.09 | 1.36 | 0.13 | 0.62 | 0.15 | 2.67 | 0.52 |
| Sex | Male vs. Female | 0.53 | 0.14 | 2.03 | 0.35 | 0.78 | 0.17 | 3.72 | 0.76 |
| Tumor size classification | Macro vs. Giant | 0.31 | 0.09 | 1.08 | 0.07 | 0.15 | 0.02 | 0.88 | 0.04 |
| CS invasion | Yes vs. No | 2.05 | 0.53 | 7.92 | 0.30 | 0.43 | 0.06 | 3.29 | 0.42 |
| Signature | High risk vs. low risk | 5.49 | 1.16 | 14.92 | 0.03 | 6.96 | 1.21 | 40.16 | 0.03 |
| Entire set (n = 66) | |||||||||
| Age | >52 vs.≤52 | 0.29 | 0.10 | 0.79 | 0.02 | 0.33 | 0.12 | 0.93 | 0.04 |
| Sex | Male vs. Female | 0.75 | 0.31 | 1.81 | 0.52 | 0.89 | 0.36 | 2.18 | 0.80 |
| Tumor size classification | Macro vs. Giant | 1.21 | 0.82 | 1.78 | 0.33 | 0.59 | 0.21 | 1.67 | 0.32 |
| CS invasion | Yes vs. No | 1.72 | 0.66 | 4.48 | 0.26 | 1.23 | 0.42 | 3.54 | 0.71 |
| Signature | High risk vs. low risk | 1.49 | 1.24 | 1.80 | <0.001 | 1.50 | 1.24 | 1.82 | <0.001 |
CS, cavernous sinus; Giant, giant adenoma; Macro, macroadenoma.